A new range of airborne disinfection systems saw its UK debut at the 3C/Medtec show last month
Based on the production of a dry H2O2 fog, the airborne disinfection systems have applications for surface disinfection in research laboratories, industrial production plants for the food, pharmaceutical, medical device sectors and hospitals.
Invented in France, the system uses a patented rapidly turning disk to produce a fog without the need for any nozzle or compressed air. As a result the systems are said to be easy to set up and maintain and provide a rapid and high level of disinfection performance. Additionally, the biocides used are compliant with the European Biocides Directive and are non-hazardous, non-toxic, environmentally safe and easy to handle and store.
The fact that there is no nozzle means there is no risk of blocking and the systems produce a constant size of droplets and liquid flow rate throughout the operation. They also avoid the creation of wetted surfaces in the proximity of the machines.
The technology is easily scalable so the range of systems can disinfect very small volumes right up to extremely large volumes. Four models are currently available.
The Phileas 20D, for treating volumes from 0.25–40m3. This has a 500ml reservoir and uses a 12V rechargeable battery giving up to 1.5hrs of operation, making it ideal for surface disinfection of isolators, laminar flow cabinets and biological safety cabinets.
With a stainless steel body, the Phileas 20I can treat volumes from 1–100m3 with its 1L reservoir. It also uses a 12V rechargeable battery making it suitable for small rooms, storage tanks and labs.
The Phileas 100 system uses 2 spinning discs, can treat from 100-500m3 with the capability to retain the treatment data for later download via a USB connection.
Finally, the Phileas 500 is equipped with a 10L reservoir and can treat volumes from 100m3 to 1500m3. It is mains powered and equipped with an integral computer and weight balance to control the machine and the diffusion of product. It also keeps records of the treatment. This model is ideal for food facilities, pharma manufacturing areas and hospitals.
Cooper Process Technologies, an agent in industrial equipment, currently holds the distribution rights to the system outside of France.